Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis.

Itchins M, Hayes SA, Gill AJ, Cooper W, O'Connell R, Howell VM, Clarke SJ, Pavlakis N.

Asia Pac J Clin Oncol. 2018 Apr 19. doi: 10.1111/ajco.12877. [Epub ahead of print]

PMID:
29675948
2.

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer.

Vardy JL, Dhillon HM, Pond GR, Renton C, Clarke SJ, Tannock IF.

ESMO Open. 2018 Feb 14;3(2):e000302. doi: 10.1136/esmoopen-2017-000302. eCollection 2018.

3.

Challenges in chemotherapy delivery: comparison of standard chemotherapy delivery to locoregional vascular mass fluid transfer.

Lane RJ, Khin NY, Pavlakis N, Hugh TJ, Clarke SJ, Magnussen J, Rogan C, Flekser RL.

Future Oncol. 2018 Mar;14(7):647-663. doi: 10.2217/fon-2017-0546. Epub 2018 Mar 7.

4.

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.

Chou A, Froio D, Nagrial AM, Parkin A, Murphy KJ, Chin VT, Wohl D, Steinmann A, Stark R, Drury A, Walters SN, Vennin C, Burgess A, Pinese M, Chantrill LA, Cowley MJ, Molloy TJ; Australian Pancreatic Cancer Genome Initiative (APGI), Waddell N, Johns A, Grimmond SM, Chang DK, Biankin AV, Sansom OJ, Morton JP, Grey ST, Cox TR, Turchini J, Samra J, Clarke SJ, Timpson P, Gill AJ, Pajic M.

Gut. 2017 Oct 28. pii: gutjnl-2017-315144. doi: 10.1136/gutjnl-2017-315144. [Epub ahead of print]

5.

Impact of reduced atmospheric CO2 and varied potassium supply on carbohydrate and potassium distribution in grapevine and grape berries (Vitis vinifera L.).

Coetzee ZA, Walker RR, Deloire AJ, Barril C, Clarke SJ, Rogiers SY.

Plant Physiol Biochem. 2017 Nov;120:252-260. doi: 10.1016/j.plaphy.2017.10.008. Epub 2017 Oct 13.

PMID:
29078143
6.

Changing Therapeutic Paradigms: Predicting mCRC Lesion Response to Selective Internal Radionuclide Therapy (SIRT) based on Critical Absorbed Dose Thresholds: A Case Study.

Willowson KP, Bernard EJ, Maher R, Clarke SJ, Bailey DL.

Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):66-69. doi: 10.22038/aojnmb.2016.7892.

7.

Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.

Itchins M, Chia PL, Hayes SA, Howell VM, Gill AJ, Cooper WA, John T, Mitchell P, Millward M, Clarke SJ, Solomon B, Pavlakis N.

Asia Pac J Clin Oncol. 2017 Aug;13 Suppl 3:3-13. doi: 10.1111/ajco.12754. Review.

PMID:
28795492
8.

Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.

Shinko D, Diakos CI, Clarke SJ, Charles KA.

Clin Pharmacol Ther. 2017 Oct;102(4):599-610. doi: 10.1002/cpt.789. Epub 2017 Aug 24. Review.

PMID:
28699186
9.

Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis.

Willowson KP, Hayes AR, Chan DLH, Tapner M, Bernard EJ, Maher R, Pavlakis N, Clarke SJ, Bailey DL.

EJNMMI Res. 2017 Dec;7(1):46. doi: 10.1186/s13550-017-0292-1. Epub 2017 May 23.

10.

Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial.

Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, Lewis C, Hui R, Blinman P, Clarke SJ, Boyer MJ, Vardy JL.

Ann Oncol. 2017 Aug 1;28(8):1889-1897. doi: 10.1093/annonc/mdx205.

PMID:
28459989
11.

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.

Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, Barnes T, Diakos C, Khasraw M, Samra J, Eslick E, Roach PJ, Engel A, Clarke SJ, Bailey DL.

Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017.

12.

Prognostic and predictive biomarkers in neuroendocrine tumours.

Chan DL, Clarke SJ, Diakos CI, Roach PJ, Bailey DL, Singh S, Pavlakis N.

Crit Rev Oncol Hematol. 2017 May;113:268-282. doi: 10.1016/j.critrevonc.2017.03.017. Epub 2017 Mar 18. Review.

PMID:
28427516
13.

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.

Chan JCY, Diakos CI, Chan DLH, Engel A, Pavlakis N, Gill A, Clarke SJ.

Ann Surg. 2018 Jun;267(6):1119-1125. doi: 10.1097/SLA.0000000000002251.

PMID:
28394869
14.

BACCN Conference 2016: A Regional Advisor Perspective.

Clarke SJ.

Nurs Crit Care. 2017 Jan;22(1):58-59. doi: 10.1111/nicc.2_12274. No abstract available.

PMID:
28058817
15.

The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.

Li BT, Barnes TA, Chan DL, Naidoo J, Lee A, Khasraw M, Marx GM, Kris MG, Clarke SJ, Drilon A, Rudin CM, Pavlakis N.

Lung Cancer. 2016 Dec;102:21-27. doi: 10.1016/j.lungcan.2016.10.004. Epub 2016 Oct 17.

16.

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.

Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frodin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Watkins DJ.

Int J Cancer. 2017 Jan 15;140(2):431-439. doi: 10.1002/ijc.30453. Epub 2016 Oct 17.

17.

Complex Microstructure and Magnetism in Polymorphic CaFeSeO.

Cassidy SJ, Batuk M, Batuk D, Hadermann J, Woodruff DN, Thompson AL, Clarke SJ.

Inorg Chem. 2016 Oct 5. [Epub ahead of print]

PMID:
27704801
18.

The Parent Li(OH)FeSe Phase of Lithium Iron Hydroxide Selenide Superconductors.

Woodruff DN, Schild F, Topping CV, Cassidy SJ, Blandy JN, Blundell SJ, Thompson AL, Clarke SJ.

Inorg Chem. 2016 Oct 3;55(19):9886-9891. Epub 2016 Sep 22.

PMID:
27656906
19.

Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.

Vardy JL, Dhillon HM, Pond GR, Renton C, Dodd A, Zhang H, Clarke SJ, Tannock IF.

Ann Oncol. 2016 Sep;27(9):1761-7. doi: 10.1093/annonc/mdw252. Epub 2016 Jul 20.

20.

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.

Giblett JP, Axell RG, White PA, Clarke SJ, McCormick L, Read PA, Reinhold J, Brown AJ, O'Sullivan M, West NE, Dutka DP, Hoole SP.

Cardiovasc Diabetol. 2016 Jul 19;15:99. doi: 10.1186/s12933-016-0416-3.

21.

Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.

Hayes SA, Haefliger S, Harris B, Pavlakis N, Clarke SJ, Molloy MP, Howell VM.

J Breath Res. 2016 Jul 5;10(3):034001. doi: 10.1088/1752-7155/10/3/034001. Review.

PMID:
27380020
22.

PET monitoring of liver directed selective internal radionuclide therapy for metastatic gastro-oesophageal cancer.

Bailey DL, Lee A, Li BT, Clarke SJ.

BMJ Case Rep. 2016 Jun 30;2016. pii: bcr2016215645. doi: 10.1136/bcr-2016-215645. No abstract available.

23.

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET).

Wong MH, Chan DL, Lee A, Li BT, Lumba S, Clarke SJ, Samra J, Pavlakis N.

PLoS One. 2016 Jun 30;11(6):e0158140. doi: 10.1371/journal.pone.0158140. eCollection 2016. Review.

24.

Analytical performance of nano-LC-SRM using nondepleted human plasma over an 18-month period.

Song X, Amirkhani A, Wu JX, Pascovici D, Zaw T, Xavier D, Clarke SJ, Molloy MP.

Proteomics. 2016 Aug;16(15-16):2118-27. doi: 10.1002/pmic.201500507. Epub 2016 Jul 25.

PMID:
27233598
25.

Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors.

Lee A, Chan DL, Wong MH, Li BT, Lumba S, Clarke SJ, Samra J, Pavlakis N.

Neuroendocrinology. 2017;104(3):209-222. doi: 10.1159/000446115. Epub 2016 Apr 16. Review.

26.

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ.

Ann Surg. 2017 Mar;265(3):539-546. doi: 10.1097/SLA.0000000000001743.

27.

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.

Charles KA, Harris BD, Haddad CR, Clarke SJ, Guminski A, Stevens M, Dodds T, Gill AJ, Back M, Veivers D, Eade T.

BMC Cancer. 2016 Feb 18;16:124. doi: 10.1186/s12885-016-2089-4.

28.

Crystal and Magnetic Structures of the Oxide Sulfides CaCoSO and BaCoSO.

Salter EJ, Blandy JN, Clarke SJ.

Inorg Chem. 2016 Feb 15;55(4):1697-701. doi: 10.1021/acs.inorgchem.5b02615. Epub 2016 Jan 29.

PMID:
26824255
29.

Erratum to: Use of diffusion magnetic resonance imaging to correlate the developmental changes in grape berry tissue structure with water diffusion patterns.

Dean RJ, Stait-Gardner T, Clarke SJ, Rogiers SY, Bobek G, Price WS.

Plant Methods. 2016 Jan 27;12:7. doi: 10.1186/s13007-016-0106-x. eCollection 2016.

30.

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.

Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frödin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Mauro DJ, Watkins DJ.

J Natl Cancer Inst. 2015 Sep 23;107(12):djv258. doi: 10.1093/jnci/djv258. Print 2015 Dec.

PMID:
26405092
31.

Pregnant women maintain body temperatures within safe limits during moderate-intensity aqua-aerobic classes conducted in pools heated up to 33 degrees Celsius: an observational study.

Brearley AL, Sherburn M, Galea MP, Clarke SJ.

J Physiother. 2015 Oct;61(4):199-203. doi: 10.1016/j.jphys.2015.08.004. Epub 2015 Sep 9.

32.

Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life.

Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, Teckle P, Tong A, Tebbutt NC, Clarke SJ, van der Hoek K, King MT, Fayers PM.

J Pain Symptom Manage. 2016 Jan;51(1):88-98. doi: 10.1016/j.jpainsymman.2015.07.013. Epub 2015 Aug 21.

PMID:
26300025
33.

Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.

McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP.

Cardiovasc Diabetol. 2015 Aug 8;14:102. doi: 10.1186/s12933-015-0259-3.

34.

REVIEW: Towards a risk register for natural capital.

Mace GM, Hails RS, Cryle P, Harlow J, Clarke SJ.

J Appl Ecol. 2015 Jun;52(3):641-653. Epub 2015 Apr 13. Review.

35.

Zero-strain reductive intercalation in a molecular framework.

Hill JA, Cairns AB, Lim JJ, Cassidy SJ, Clarke SJ, Goodwin AL.

CrystEngComm. 2015 Apr 21;17(15):2925-2928. Epub 2015 Jan 16.

36.

Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.

Jankova L, Dent OF, Molloy MP, Chan C, Chapuis PH, Howell VM, Clarke SJ.

Proteomics Clin Appl. 2015 Dec;9(11-12):1078-86. doi: 10.1002/prca.201400177. Epub 2015 May 7.

PMID:
25755195
37.

Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.

McCormick LM, Hoole SP, White PA, Read PA, Axell RG, Clarke SJ, O'Sullivan M, West NEJ, Dutka DP.

JACC Cardiovasc Interv. 2015 Feb;8(2):292-301. doi: 10.1016/j.jcin.2014.09.014.

38.

Soft chemical control of superconductivity in lithium iron selenide hydroxides Li(1-x)Fe(x)(OH)Fe(1-y)Se.

Sun H, Woodruff DN, Cassidy SJ, Allcroft GM, Sedlmaier SJ, Thompson AL, Bingham PA, Forder SD, Cartenet S, Mary N, Ramos S, Foronda FR, Williams BH, Li X, Blundell SJ, Clarke SJ.

Inorg Chem. 2015 Feb 16;54(4):1958-64. doi: 10.1021/ic5028702. Epub 2015 Jan 23.

39.

Spin-reorientation transition in CeMnAsO.

Corkett AJ, Free DG, Clarke SJ.

Inorg Chem. 2015 Feb 2;54(3):1178-84. doi: 10.1021/ic5026608. Epub 2014 Dec 3.

PMID:
25470219
40.

Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories.

Zhou J, Belov L, Chapuis P, Chan C, Armstrong N, Kaufman KL, Solomon MJ, Clarke SJ, Christopherson RI.

J Immunol Methods. 2015 Jan;416:59-68. doi: 10.1016/j.jim.2014.11.001. Epub 2014 Nov 9.

PMID:
25445327
41.

Use of diffusion magnetic resonance imaging to correlate the developmental changes in grape berry tissue structure with water diffusion patterns.

Dean RJ, Stait-Gardner T, Clarke SJ, Rogiers SY, Bobek G, Price WS.

Plant Methods. 2014 Nov 4;10(1):35. doi: 10.1186/1746-4811-10-35. eCollection 2014. Erratum in: Plant Methods. 2016;12:7.

42.

Cancer-related inflammation and treatment effectiveness.

Diakos CI, Charles KA, McMillan DC, Clarke SJ.

Lancet Oncol. 2014 Oct;15(11):e493-503. doi: 10.1016/S1470-2045(14)70263-3. Review.

PMID:
25281468
43.

Cognitive function and fatigue after diagnosis of colorectal cancer.

Vardy J, Dhillon HM, Pond GR, Rourke SB, Xu W, Dodd A, Renton C, Park A, Bekele T, Ringash J, Zhang H, Burkes R, Clarke SJ, Tannock IF.

Ann Oncol. 2014 Dec;25(12):2404-12. doi: 10.1093/annonc/mdu448. Epub 2014 Sep 11.

44.

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Hudson AL, Weir C, Moon E, Harvie R, Klebe S, Clarke SJ, Pavlakis N, Howell VM.

Sci Rep. 2014 Aug 21;4:6152. doi: 10.1038/srep06152.

45.

The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study.

Tan CS, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ.

Support Care Cancer. 2015 Feb;23(2):385-91. doi: 10.1007/s00520-014-2385-y. Epub 2014 Aug 13.

PMID:
25112562
46.

Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.

Chik JH, Zhou J, Moh ES, Christopherson R, Clarke SJ, Molloy MP, Packer NH.

J Proteomics. 2014 Aug 28;108:146-62. doi: 10.1016/j.jprot.2014.05.002. Epub 2014 May 17.

PMID:
24840470
47.

Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.

Sonpavde G, Pond GR, Armstrong AJ, Clarke SJ, Vardy JL, Templeton AJ, Wang SL, Paolini J, Chen I, Chow-Maneval E, Lechuga M, Smith MR, Michaelson MD.

Clin Genitourin Cancer. 2014 Oct;12(5):317-24. doi: 10.1016/j.clgc.2014.03.005. Epub 2014 Mar 15.

PMID:
24806399
48.

Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines.

Weir C, Hudson AL, Moon E, Ross A, Alexander M, Peters L, Langova V, Clarke SJ, Pavlakis N, Davey R, Howell VM.

Cancer Immunol Res. 2014 May;2(5):469-79. doi: 10.1158/2326-6066.CIR-13-0157. Epub 2014 Feb 21.

49.

From mice to men: GEMMs as trial patients for new NSCLC therapies.

Hayes SA, Hudson AL, Clarke SJ, Molloy MP, Howell VM.

Semin Cell Dev Biol. 2014 Mar;27:118-27. doi: 10.1016/j.semcdb.2014.04.002. Epub 2014 Apr 6. Review.

PMID:
24718320
50.

Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1.

Clarke SJ, McCormick LM, Dutka DP.

Cardiovasc Diabetol. 2014 Jan 11;13:12. doi: 10.1186/1475-2840-13-12. Review.

Supplemental Content

Loading ...
Support Center